Gilead announces data from interim analysis of Phase 3 ASSURE study
Sciences announced data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study, which showed that 81%, ...
Biotech giant Gilead lays off 104 from Bay Area headquarters, including execs
Gilead Sciences, the Bay Area biotech giant best known for its popular HIV drugs and COVID-19 treatment Remdesivir, is laying off 104 workers from its Foster City headquarters. The company has also ...